EIT Health presenta sus programas de financiación, formación y soporte para 2017
24 Feb 17
EIT Health, el mayor consorcio europeo en el ámbito de la innovación y el emprendimiento para una vida saludable y
EIT Health, el mayor consorcio europeo en el ámbito de la innovación y el emprendimiento para una vida saludable y
Health, Demographic Change & Wellbeing challenge in Horizon 2020 Do you intend to prepare a proposal for the challenge in
Scientists are meeting to develop a better prognostic tool for the progression of breast cancer in its early stages. Today
Today, on the 25th of November, the Forum biocat is taking place in Barcelona at the Palau de Congressos de
As the highlight of EIT Health’s first year of activities, the Summit – that will take place on 23-24 November
On the 3rd and 4th of November 2016, the GLAM consortium met in Castelldefels (Barcelona) at ICFO facilities for the
TheraYAP A tailored and rational approach for treating cancer patients with a YAP-TEAD inhibitor www.atryshealth.com/es/therayap ABSTRACT The main objective of
HYPOSENS Nano-confined photonic system for detection of breast cancer spread to the lymph nodes hyposens.eu The Vision of HypoSens is
The Nanomedicine European Technology Platform will meet in Heraklion (Greece) for its 11th annual event from the 12th to the
On the 6th and 7th of October, EIT Health is organising a bilateral meeting between Spain and Scandinavia in Barcelona.
This 2016, Aspetar, FC Barcelona, and Leitat have been collaborating to gather some of the most internationally recognized specialists and
DIALCAT Diabetes as an accelerator of cognitive deterioration and Alzheimer’s disease, boarding and adherence Objective: Prevention of Alzheimer disease in
NANONAFRES Preclinical and Clinical Studies of Nanovesicles (Quatsomes) with EGF for Chronic Venous Ulcers Objective: Conduct preclinical studies and clinical
TEC-SALUT Technologies Applied to Health healthcarelivinglab.cat/tec-salut The objective of TEC-SALUT is to create a space for collaborative work in the
On the 13th and 14th of September 2016, the European Commission organises a workshop entitled Cross-cutting Key Enabling Technologies for
El 25 de julio, ACCIÓ presentó las cinco primeras comunidades acreditadas RIS3CAT. RIS3CAT es la estrategia del gobierno catalán para
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300
